Piantoni Chiara, Carnevali Luca, Molla David, Barbuti Andrea, DiFrancesco Dario, Bucchi Annalisa, Baruscotti Mirko
Department of Biosciences, The PaceLab and "Centro Interuniversitario di Medicina Molecolare e Biofisica Applicata", Università degli Studi di Milano, Milan, Italy.
Institute of Neurophysiology, Hannover Medical School, Hanover, Germany.
Front Neurosci. 2021 May 17;15:617698. doi: 10.3389/fnins.2021.617698. eCollection 2021.
The aim of this study was to assess age-related changes in cardiac autonomic modulation and heart rate variability (HRV) and their association with spontaneous and pharmacologically induced vulnerability to cardiac arrhythmias, to verify the translational relevance of mouse models for further in-depth evaluation of the link between autonomic changes and increased arrhythmic risk with advancing age.
Heart rate (HR) and time- and frequency-domain indexes of HRV were calculated from Electrocardiogram (ECG) recordings in two groups of conscious mice of different ages (4 and 19 months old) (i) during daily undisturbed conditions, (ii) following peripheral β-adrenergic (atenolol), muscarinic (methylscopolamine), and β-adrenergic + muscarinic blockades, and (iii) following β-adrenergic (isoprenaline) stimulation. Vulnerability to arrhythmias was evaluated during daily undisturbed conditions and following β-adrenergic stimulation.
HRV analysis and HR responses to autonomic blockades revealed that 19-month-old mice had a lower vagal modulation of cardiac function compared with 4-month-old mice. This age-related autonomic effect was not reflected in changes in HR, since intrinsic HR was lower in 19-month-old compared with 4-month-old mice. Both time- and frequency-domain HRV indexes were reduced following muscarinic, but not β-adrenergic blockade in younger mice, and to a lesser extent in older mice, suggesting that HRV is largely modulated by vagal tone in mice. Finally, 19-month-old mice showed a larger vulnerability to both spontaneous and isoprenaline-induced arrhythmias.
The present study combines HRV analysis and selective pharmacological autonomic blockades to document an age-related impairment in cardiac vagal modulation in mice which is consistent with the human condition. Given their short life span, mice could be further exploited as an aged model for studying the trajectory of vagal decline with advancing age using HRV measures, and the mechanisms underlying its association with proarrhythmic remodeling of the senescent heart.
本研究旨在评估心脏自主神经调节和心率变异性(HRV)随年龄的变化及其与自发性和药物诱导的心律失常易感性的关系,以验证小鼠模型在进一步深入评估自主神经变化与年龄增长导致的心律失常风险增加之间联系的转化相关性。
在两组不同年龄(4个月和19个月大)的清醒小鼠中,根据心电图(ECG)记录计算心率(HR)以及HRV的时域和频域指标:(i)在日常不受干扰的情况下;(ii)在外周β-肾上腺素能(阿替洛尔)、毒蕈碱(甲基东莨菪碱)以及β-肾上腺素能+毒蕈碱阻断后;(iii)在β-肾上腺素能(异丙肾上腺素)刺激后。在日常不受干扰的情况下以及β-肾上腺素能刺激后评估心律失常易感性。
HRV分析以及HR对自主神经阻断的反应显示,与4个月大的小鼠相比,19个月大的小鼠心脏功能的迷走神经调节较低。这种与年龄相关的自主神经效应未反映在HR变化中,因为19个月大的小鼠的固有HR低于4个月大的小鼠。在年轻小鼠中,毒蕈碱阻断后时域和频域HRV指标均降低,但β-肾上腺素能阻断后未降低,而在老年小鼠中降低程度较小,这表明小鼠的HRV在很大程度上受迷走神经张力调节。最后,19个月大的小鼠对自发性和异丙肾上腺素诱导的心律失常均表现出更高的易感性。
本研究结合HRV分析和选择性药理学自主神经阻断,证明了小鼠心脏迷走神经调节存在与年龄相关的损害,这与人类情况一致。鉴于小鼠寿命较短,可进一步将其用作老年模型,利用HRV测量研究随着年龄增长迷走神经功能下降的轨迹及其与衰老心脏促心律失常重塑相关的机制。